ESR1 and triple-negative breast carcinoma: Previously, we applied quantitative structure–activity relationship (QSAR) analysis to a series of arylsulfonylhydrazones, identifying key structural determinants of anticancer activity against estrogen receptor-positive (ER+) MCF-7 and triple-negative breast cancer (TNBC) MDA-MB-231 cell lines [48].